Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I don’t have as many shares as you do but my 17k holding should provide a nice little income over the coming weeks, months & years.
Surprises coming next week.
You’re killing me lol
SHIB BURN SITE-https://www.shibburn.com/ Shib Army ranks:
To funny
Agreed. 2022 will be an extraordinary year.
Looking good.
New news….
QIXLEEF™ Aerosol Meets the Criteria Established by the U.S. FDA for Delivery of Inhalation Aerosols
11/29/2021
Tetra Bio-Pharma Confirms Meeting with the FDA to Align on the Requirements for Marketing Authorization
OTTAWA, ON, Nov. 29, 2021 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development today announced that it received a letter from the United States Food and Drug Administration (FDA), granting a Type C meeting to discuss safety and labelling requirements for obtaining marketing approval under the 505(b)(1) regulatory pathway for its QIXLEEF™.
Tetra Bio-Pharma Inc. (CNW Group/Tetra Bio-Pharma Inc.)
QIXLEEF™ is a botanical inhaled investigational new drug with a fixed ratio of THC and CBD that meets USA cGMP regulatory requirements. The delivered-dose uniformity (DDU) of the aerosol generated by the Mighty Medic® medical device meets the criteria established by FDA for inhalation aerosols (also known as metered dose inhalers (or MDIs)) and inhalation powders (also known as dry powder inhalers (or DPIs)). The DDU is a measure of the drug discharged from the mouthpiece of an inhalation device and compares that measurement to the target delivered dose. Meeting the DDU specification is critical for a quality inhaled drug product.
Earlier this year, Tetra announced it received from the Malta Medicines Authority (MAA) a Scientific Advice Assessment (SAA) Report. The Report provided positive feedback on Tetra's drug development plan for QIXLEEF™ and eligibility for submitting a Marketing Authorization Application (MAA) under Directive 2001/83/EC (Directive). The SAA Report endorsed Tetra's proposed plan to address the nonclinical safety requirements for submitting a marketing approval application for QIXLEEF™.
These safety studies are both time consuming and very costly and can impact the timing of the submission of a marketing application. Dr. Guy Chamberland, Chief Executive Officer (CEO) and Chief Regulatory Officer (CRO) of Tetra Bio-Pharma said "the MAA's response confirmed that our nonclinical safety strategy is acceptable and would satisfy the requirements of article 8 of the Directive. Now we need to obtain the FDA's final guidance on this strategy to ensure QIXLEEF™ makes it to the market at the lowest cost."
About Tetra Bio-Pharma
Tetra Bio-Pharma (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Their evidence-based scientific approach has enabled them to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. With patients at the core of what they do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing biopharma industry by regulators, physicians and insurance companies.
For more information visit: www.tetrabiopharma.com look
Question; Are the members still in position?
Most significant games of all time.
https://share.smartnews.com/NKbVZ
Just waiting for Orphan. Me & my members are ‘just’ about ready. Lol
You’ve been posting this crap for three weeks. Let along on three different crypto threads.
Same line on all three threads.
Bye bye. I’ll wait out
That would be nice
Because they can’t make money promoting crypto.
Lol. Enjoy
Tucson, nice. Just retired up in Oracle. Saddlebrooke Ranch.
It’s good
No ATM offering. Terminated!
Open SmartNews and read "A SHIB Whale Just Moved Nearly $3 Billion Worth of the Meme Coin" here: https://share.smartnews.com/Ft2G8
To read it on the web, tap here: https://share.smartnews.com/t6gKf
19, 11, 24, 5
19, 11, 24 (19)
Three straight UP days. Wonder what next week brings
Gotta earn a living somehow.
Then by all means, keep helping us poor souls.
Or they already missed the opportunity so they come back pumping another coin.
What street is that? 42nd & Broadway?
You guys crack me up
Thanks aCryptoKing those are nice reminders of what’s coming.
How’s that 6+year investigation going? Funny that Milkin, Boesky & Steward had investigations of less than 2 1/2 years.
Brent must be a bad bad man. Lol
True.
I’ve got a feeling that RH won’t list Shiba until they finish and roll out their crypto wallets.
I hope I’m wrong
The operative word is ‘news’
Fox News. Now that’s an oxymoron
Another UP day
SEC closing fast! 6+ years lol
Any time. It’s still SO early
You guys really need to give it up. There are 15 people watching this stock on IHUB and you haven’t convinced anyone of them to sell. Lol